CORC

在结果中检索

CORC

浏览/检索结果: 共99条，第1-10条 帮助

限定条件                    
已选(0)清除 条数/页：   排序方式：
Price Forecast of Building Materials Based on GM (1,1) Model 会议论文
作者:  Wu, Chunfeng;  Zhang, Zhuai;  Zhang, Sheng
收藏  |  浏览/下载：4/0  |  提交时间：2019/12/05
THE EFFICACY AND SAFETY OF RAVIDASVIR COMBINED WITH DANOPREVIR IN THE 12-WEEK ORAL REGIMEN FOR TREATMENT-NAIVE HCV GENOTYPE 1 ADULT PATIENTS WITHOUT CIRRHOSIS IN CHINA: PHASE II/III CLINICAL TRIAL 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Zheng, Sujun;  Guan, Yujuan;  Sheng, Jifang
收藏  |  浏览/下载：36/0  |  提交时间：2019/12/05
SSIM-based Weak Zero-forcing Precoder Design for Multiuser MIMO System 会议论文
作者:  Zhou, Lunxiong;  Sheng, Yuxia;  Chai, Li;  Zhang, Jingxin
收藏  |  浏览/下载：4/0  |  提交时间：2019/12/05
A robust, practical upper limb electromyography interface using dry 3D printed electrodes 会议论文
作者:  Abass, Ziad;  Meng, Wei;  Xie, Sheng Quan;  Zhang, Zhiqiang
收藏  |  浏览/下载：8/0  |  提交时间：2019/12/05
Girder crack of concrete single pylon cable-stayed bridge 会议论文
作者:  Yong-Jian, Zuo;  Deng, Li;  Sheng, Zhang;  Li-Rong-Jun, Ying
收藏  |  浏览/下载：17/0  |  提交时间：2019/12/05
Multi-objective optimization for pure electric vehicle during a car-following process 会议论文
作者:  Zhang, Sheng;  Zhuan, Xiangtao
收藏  |  浏览/下载：6/0  |  提交时间：2019/12/05
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载：38/0  |  提交时间：2019/12/05
THE EFFICACY AND SAFETY OF RAVIDASVIR COMBINED WITH DANOPREVIR IN THE 12-WEEK ORAL REGIMEN FOR TREATMENT-NAIVE HCV GENOTYPE 1 ADULT PATIENTS WITHOUT CIRRHOSIS IN CHINA: PHASE II/III CLINICAL TRIAL 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Zheng, Sujun;  Guan, Yujuan;  Sheng, Jifang
收藏  |  浏览/下载：32/0  |  提交时间：2019/12/05
参松养心对阵发性房颤进展的影响与自主神经活动的调节有关 会议论文
作者:  Yi-Zhao;  Shu-Di-Zhang;  Kai-Zhang;  Xi-Wang;  Qing-Yan-Zhao
收藏  |  浏览/下载：21/0  |  提交时间：2019/12/05
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载：30/0  |  提交时间：2019/12/05

©版权所有 ©2017 CSpace - Powered by CSpace